Researchers
Jeličić, Jelena
Results 1-20 of 78
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | International Prognostic Models as Tools for Selection of Higher-risk Trial-eligible Patients With Diffuse Large B-Cell lymphoma | Jelicic, Jelena J.  ; Juul-Jensen, Karen; Bukumirić, Zoran M.  ; Simonsen, Mikkel Runason; Clausen, Michael Roost; Al-Mashhadi, Ahmed Ludvigsen; Pedersen, Robert Schou; Poulsen, Christian Bjorn; Gang, Anne Ortved; Brown, Peter;
El-Galaly, Tarec Christoffer; Larsen, Thomas Stauffer;
| Article | 22M22 |
| 2025 | Challenges in comparing outcomes of frontline clinical trials for diffuse large B-cell lymphoma patients selected based on the international index: A real-world from the danish lymphoma registry | Jelicic, Jelena ; Juul-Jensen, Karen; Bukumirić, Zoran ; Jorgensen, Rasmus Rask Kragh; Simonsen, Mikkel Runason; Clausen, Michael Roost; Al-Mashhadi, Ahmed; Pedersen, Robert; Poulsen, Christian; Gang, Anne Ortved;
Brown, Peter; El-Galaly, Tarec Christoffer; Larsen, Thomas Stauffer;
| Conference Paper | Mp. category will be shown later |
| 2025 | Validation of prognostic models in elderly patients with diffuse large B-cell lymphoma in a real-world nationwide population-based study - development of a clinical nomogram | Jeličić, Jelena J. ; Juul, Jensen Karen; Bukumirić, Zoran M. ; Runason, Simonsen Mikkel; Kragh, Jorgensen Rasmus Rask; Roost, Clausen Michael; Ludvigsen, Al Mashhadi Ahmed; Schou, Pedersen Robert; Bjorn, Poulsen Christian; Ortved, Gang Anne;
Brown, Peter; El Galaly, Tarec Christoffer; Stauffer, Larsen Thomas;
| Article | 21M21 |
| 2025 | Validation of US Consensus Eligibility Criteria for Front-Line DLBCL Trials | Jeličić, Jelena J. ; Juul-jensen, Karen; Bukumirić, Zoran M. ; Rask Kragh Jorgensen, Rasmus; Runason Simonsen, Mikkel; Roost Clausen, Michael; Ludvigsen Al-mashhadi, Ahmed; Schou Pedersen, Robert; Poulsen, Christian Bjorn; Gang, Anne Ortved;
Brown, Peter; El-galaly, Tarec Christoffer; Stauffer Larsen, Thomas;
| Article | 22M22 |
| 2024 | Should we use nomograms for risk predictions in diffuse large B cell lymphoma patients? A systematic review | Jeličić, Jelena J. ; Larsen, Thomas Stauffer; Anđelić, Boško M.; Juul, Jensen Karen; Bukumirić, Zoran M. | Reviews | 21M21 |
| 2024 | Identifying Trial-Eligible High- and High-Intermediate Risk Patients with Diffuse Large B-Cell Lymphoma Using Prognostic Models: A Real-Life Comparative Analysis of IPI, aaIPI and NCCN-IPI from Danish Study Group | Jeličić, Jelena ; Juul-Jensen, Karen; Bukumirić, Zoran ; Simonsen, Mikkel Runason; Clausen, Michael Roost; Al Mashhadi, Ahmed; Pedersen, Robert Schou; Poulsen, Christian Bjorn; Ortved Gang, Anne; Brown, Peter;
El Galaly, Tarec Christoffer Christoffer; Stauffer Larsen, Thomas;
| Conference Paper | Mp. category will be shown later |
| 2024 | Revisiting beta-2 microglobulin as a prognostic marker in diffuse large B-cell lymphoma | Jeličić, Jelena J. ; Juul-Jensen, Karen; Bukumirić, Zoran M. ; Runason Simonsen, Mikkel; Roost Clausen, Michael; Ludvigsen Al-Mashhadi, Ahmed; Schou Pedersen, Robert; Bjørn Poulsen, Christian; Ortved Gang, Anne; Brown, Peter;
El-Galaly, Tarec Christoffer; El-Galaly, Tarec Christoffer;
| Article | 21M21 |
| 2023 | Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models | Jeličić, Jelena J. ; Juul-Jensen, Karen; Bukumirić, Zoran M. ; Clausen, Michael Roost; Ludvigsen, Al-Mashhadi Ahmed; Pedersen, Robert Schou; Poulsen, Christian Bjorn; Brown, Peter; El-Galaly, Tarec Christoffer; Stauffer, Larsen Thomas | Article | 21aM21a |
| 2023 | A Population-Based Study on Performance of Clinical Prognostic Models in Patients with Diffuse Large B-Cell Lymphoma Younger Than 70 Years | Jeličić, Jelena J. ; Juul-Jensen, Karen; Bukumirić, Zoran M. ; Roost Clausen, Michael; Ludvigsen Al-Mashhadi, Ahmed; Schou Pedersen, Robert; Bjorn Poulsen, Christian; de Nully Brown, Peter; Christoffer Christoffer El-Galaly, Tarec; Stauffer Larsen, Thomas | Conference Paper | Mp. category will be shown later |
| 2022 | Clinical Characteristics and Management of Patients With Concomitant Liver Cirrhosis and Lymphoma: A Systematic Review | Jeličić, Jelena J. ; Larsen, Thomas Stauffer; Fialla, Annette Dam; Bukumirić, Zoran M. ; Anđelić, Boško M. | Article | 22M22 |
| 2021 | Ultra-high-risk prognostic significance of double and triple hit myeloma | Bila, Jelena S. ; Mitrović, Marko; Bukumirić, Zoran M. ; Jovanović, Jelica V.; Denčić-Fekete, Marija ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A. | Conference Paper | Mp. category will be shown later |
| 2021 | Prognostic models in primary central nervous system lymphoma patients: A systematic review | Jeličić, Jelena J. ; Larsen, Thomas Stauffer; Bukumirić, Zoran M. ; Juul-Jensen, Karen; Andjelic, Bosko M. | Article | 21aM21a |
| 2021 | The clinical applicability of current prognostic models in follicular lymphoma: A systematic review | Jeličić, Jelena J. ; Stauffer-Larsen, Thomas; Bukumirić, Zoran M. ; Andjelic, Boško M. | Article | 21aM21a |
| 2020 | Influence of applied CD34+ cell dose on the survival of Hodgkin's lymphoma and multiple myeloma patients following autologous stem cell transplants | Todorović-Balint, Milena ; Bila, Jelena ; Balint, Bela ; Jeličić, Jelena ; Đunić, Irena ; Antić, Darko ; Kraguljac-Kurtović, Nada ; Vujić, Dragana ; Mihaljević, Biljana | Article | 23M23 |
| 2020 | Statistical challenges in development of prognostic models in diffuse large b-cell lymphoma: Comparison between existing models – A systematic review | Jeličić, Jelena J. ; Stauffer-Larsen, Thomas; Frederiksen, Henrik; Anđelić, Boško M.; Maksimović, Miloš Z.; Bukumirić, Zoran M. | Article | 21aM21a |
| 2019 | Available prognostic models for risk stratification of diffuse large B cell lymphoma patients: a systematic review | Jelicic, Jelena J ; Larsen, Thomas Stauffer; Maksimovic, Milos Z; Trajkovic, Goran Z | Article | 21aM21a |
| 2018 | 25(OH) vitamin D deficiency in lymphoid malignancies, its prevalence and significance. Are we fully aware of it? | Đurašinović, Vladislava T.; Mihaljević, Biljana ; Šipetić-Grujičić, Sandra B. ; Ignjatović, Svetlana ; Trajković, Goran ; Todorović-Balint, Milena R. ; Antić, Darko ; Bila, Jelena S. ; Anđelić, Boško M.; Jeličić, Jelena J. ;
Vuković, Vojin M.
; Nikolić, Aleksandra M. ; Klek, Stanislaw; | Article | 21aM21a |
| 2018 | Fish in Multiple Myeloma: Benefits and Obstacles | Denčić-Fekete, Marija ; Bila, Jelena S. ; Jeličić, Jelena J. ; Sretenović, Aleksandra M.; Jovanović, Jelica V.; Peruničić-Jovanović, Maja D. ; Jaković, Ljubomir R. ; Bogdanović, Andrija D. ; Mihaljević, Biljana S. | Conference Paper | Mp. category will be shown later |
| 2018 | Is it possible to improve prognostic value of NCCN-IPI in patients with diffuse large B cell lymphoma? The prognostic significance of comorbidities | Antic, Darko A ; Jelicic, Jelena J ; Trajkovic, Goran Z; Todorovic-Balint, Milena R; Bila, Jelena S ; Markovic, Olivera B; Petkovic, Ivan Z ; Nikolic, Vesna; Andjelic, Bosko M; Djurasinovic, Vladislava T;
Sretenovic, Aleksandra M; Smiljanic, Mihailo; Vukovic, Vojin M
; Mihaljevic, Biljana S ; | Article | 22M22 |
| 2018 | Venous thromboembolic events in lymphoma patients: Actual relationships between epidemiology, mechanisms, clinical profile and treatment | Antić, Darko ; Jeličić, Jelena ; Vuković, Vojin ; Nikolovski, Srđan ; Mihaljević, Biljana | Article | 21aM21a |